scholarly journals Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer

Oncotarget ◽  
2016 ◽  
Vol 7 (34) ◽  
pp. 54702-54713 ◽  
Author(s):  
Ai N.H. Phan ◽  
Tuyen N.M. Hua ◽  
Min-Kyu Kim ◽  
Vu T.A. Vo ◽  
Jong-Whan Choi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitors ◽  
Egf Receptor ◽  
Acquired Resistance ◽  
Small Cell ◽  
Small Cell Lung ◽  
Stat3 Signaling ◽  
Receptor Tyrosine Kinase Inhibitors

Radiotherapy of non-small-cell lung cancer in the era ofEGFRgene mutations and EGF receptor tyrosine kinase inhibitors

2015 ◽  
Vol 11 (16) ◽  
pp. 2329-2342 ◽  
Author(s):  
Ilaria Moschini ◽  
Cristina Dell'Anna ◽  
Pier Luigi Losardo ◽  
Paola Bordi ◽  
Nunziata D'Abbiero ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitors ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitors ◽  
Egf Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Receptor Tyrosine Kinase Inhibitors

Management of EGFR-mutant non-small-cell lung cancer patients after first-line reversible EGF receptor-tyrosine kinase inhibitors

2014 ◽  
Vol 3 (1) ◽  
pp. 77-84
Author(s):  
Anna Manzo ◽  
Carminia Maria Della Corte ◽  
Lucia Festino ◽  
Morena Fasano ◽  
Fortunato Ciardiello ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitors ◽  
Egf Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
Egfr Mutant ◽  
Receptor Tyrosine Kinase Inhibitors
Sign in / Sign up

Export Citation Format

Share Document